Keystone Resort Floorplan
Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2013
Here are the related meetings in 2020:
Obesity and NAFLD: Mechanisms and Therapeutics (B3)
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Adipose Tissue Biology (J5)
Organizer(s) Susan K. Fried and Anthony W. Ferrante
January 27—February 1, 2013
Keystone Resort • Keystone, CO USA
Abstract Deadline: Sep 27, 2012
Late Abstract Deadline: Oct 29, 2012
Scholarship Deadline: Sep 27, 2012
Early Registration Deadline: Nov 28, 2012
Supported by the Directors' Fund
Summary of Meeting:
Adipocytes are central players in the development of obesity and associated metabolic syndromes. Key areas of ongoing research in this field focus on basic mechanisms that modulate the lifespan of adipocytes, explain how resident and recruited immune cell populations influence adipose tissue remodeling and metabolic function, contribute to the functional heterogeneity of white as well as brown adipose tissue depots, and link alterations in adipocyte function to disease risk. The next few years will bring the application of new technologies and nextgen sequencing, and will likely yield unanticipated insights into developmental and functional aspects of adipocyte biology. Thus, an important goal of the meeting is to engage researchers from diverse fields to take basic discoveries in adipocyte biology to the next level, including a deepening understanding the etiology of type 2 diabetes through our joint meeting, as well as correlated diseases such as cancer, dementia and asthma. The meeting goals are: 1) to foster cross-talk between basic researchers working on model systems with those studying mammalian models and clinical/translational aspects; 2) to integrate emerging knowledge of the myriad roles of adipose tissue in understanding mechanisms linking the degree of adiposity and adipose tissue distribution to disease; and 3) to disseminate knowledge of new technologies that can deepen and broaden knowledge of adipocyte biology in vivo and in vitro. Attendees will take away a more diverse knowledge of the field and an awareness of potential new mechanistic connections and therapeutic opportunities.
View Scholarships/Awards
Adipocytes are central players in the development of obesity and associated metabolic syndromes. Key areas of ongoing research in this field focus on basic mechanisms that modulate the lifespan of adipocytes, explain how resident and recruited immune cell populations influence adipose tissue remodeling and metabolic function, contribute to the functional heterogeneity of white as well as brown adipose tissue depots, and link alterations in adipocyte function to disease risk. The next few years will bring the application of new technologies and nextgen sequencing, and will likely yield unanticipated insights into developmental and functional aspects of adipocyte biology. Thus, an important goal of the meeting is to engage researchers from diverse fields to take basic discoveries in adipocyte biology to the next level, including a deepening understanding the etiology of type 2 diabetes through our joint meeting, as well as correlated diseases such as cancer, dementia and asthma. The meeting goals are: 1) to foster cross-talk between basic researchers working on model systems with those studying mammalian models and clinical/translational aspects; 2) to integrate emerging knowledge of the myriad roles of adipose tissue in understanding mechanisms linking the degree of adiposity and adipose tissue distribution to disease; and 3) to disseminate knowledge of new technologies that can deepen and broaden knowledge of adipocyte biology in vivo and in vitro. Attendees will take away a more diverse knowledge of the field and an awareness of potential new mechanistic connections and therapeutic opportunities.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
SUNDAY, JANUARY 27
MONDAY, JANUARY 28
TUESDAY, JANUARY 29
WEDNESDAY, JANUARY 30
THURSDAY, JANUARY 31
FRIDAY, FEBRUARY 1
Conference Program Print | View meeting in 24 hr (international) time
SUNDAY, JANUARY 27
8:00—9:00 AM
Welcome and Keynote Address (Joint)
*
Susan K. Fried,
Icahn School of Medicine at Mount Sinai, USA
*
C. Ronald Kahn,
Joslin Diabetes Center and Harvard Medical School, USA
Craig B. Thompson,
Memorial Sloan Kettering Cancer Center, USA
Metabolic Regulation in Cancer Biology
Metabolic Regulation in Cancer Biology
9:00—11:00 AM
Mechanisms of Metabolic Dysfunction and New Therapeutic Targets for Diabetes and Obesity (Joint)
*
David E. Kelley,
Merck & Co., Inc., USA
*
David E. Moller,
Eli Lilly and Company, USA
Bruce M. Spiegelman,
Harvard Medical School, USA
Control of Beige Fat Thermogenesis: Toward a New Generation of Therapeutics
Control of Beige Fat Thermogenesis: Toward a New Generation of Therapeutics
David J. Mangelsdorf,
University of Texas Southwestern Medical Center, USA
Journal of Lipid Research Lectureship Award Presented by Kathryn Moore: Regulation of Nutrient Metabolism by FGF21
Journal of Lipid Research Lectureship Award Presented by Kathryn Moore: Regulation of Nutrient Metabolism by FGF21
Philippe Froguel,
Imperial College of London, UK
Germline and Somatic Clonal Genomic Structure Events in Diabetes and Obesity and their Relation with Associated Diseases
Germline and Somatic Clonal Genomic Structure Events in Diabetes and Obesity and their Relation with Associated Diseases
11:00 AM—12:00 PM
APSA Panel on Career Development (Joint)
Jennifer M. Kwan, APSA Policy Chair and Vice President of External Affairs,
and Laina King, Director, Diversity in Life Science Programs at Keystone Symposia,
will lead a discussion on ways early-career investigators can enhance their
professional development skills, particularly in the areas of translational research
and biomedical discovery.
*
Jennifer M. Kwan,
University of Illinois, Chicago, USA
*
Laina King,
Keystone Symposia, USA
C. Ronald Kahn,
Joslin Diabetes Center and Harvard Medical School, USA
David E. Kelley,
Merck & Co., Inc., USA
Anne C. Ferguson-Smith,
University of Cambridge, UK
Randy S. Levinson,
Cell Press, USA
2:30—4:30 PM
Workshop 1: 8 Shades of Brown
*
Sheila Collins,
Vanderbilt University Medical Center, USA
*
Jan Nedergaard,
Stockholm University, Sweden
*
Barbara Cannon,
Stockholm University, Sweden
Introduction and Overview
Introduction and Overview
Nicholas Douris,
Beth Israel Deaconess Medical Center, Harvard Medical School, USA
FGF21 Stimulates Browning of White Adipose Tissue via Direct Action on the Brain
FGF21 Stimulates Browning of White Adipose Tissue via Direct Action on the Brain
Shingo Kajimura,
University of California, San Francisco, USA
Molecular Control of Brown Adipose Cell Fate and Energy Homeostasis through a PRDM16 Transcriptional Complex
Molecular Control of Brown Adipose Cell Fate and Energy Homeostasis through a PRDM16 Transcriptional Complex
Therese J. Larsen,
Rigshospitalet, University of Copenhagen, Denmark
Adipose Tissue from Supraclavicular Region of Adult Humans Display Classical Brown Fat Signature
Adipose Tissue from Supraclavicular Region of Adult Humans Display Classical Brown Fat Signature
Annie Moisan,
Roche Pharmaceuticals, Switzerland
A Screening Platform to Identify Regulators of Human Adipocyte Cell Fate
A Screening Platform to Identify Regulators of Human Adipocyte Cell Fate
Kathleen Ogilvie,
aTyr Pharma, USA
Do Adipocyte Cell Lines Reliably Respond to Pharmacological Agents which Recruit a Beige-Cell Gene Signature in Vivo?
Do Adipocyte Cell Lines Reliably Respond to Pharmacological Agents which Recruit a Beige-Cell Gene Signature in Vivo?
Hai-Bin Ruan,
University of Minnesota, USA
Nutrient-Sensitive O-GlcNAc Signaling in AgRP Neurons Regulates Adipocyte Browning and Energy Homeostasis
Nutrient-Sensitive O-GlcNAc Signaling in AgRP Neurons Regulates Adipocyte Browning and Energy Homeostasis
Courtney M. Anderson,
University of California, Berkeley, USA
Requirement of the Scavenger Receptor CD36 for Brown Adipose Tissue Mitochondrial Function
Requirement of the Scavenger Receptor CD36 for Brown Adipose Tissue Mitochondrial Function
2:30—4:30 PM
Workshop 1: New Aspects of Insulin Signaling and Insulin Resistance
*
Domenico Accili,
Columbia University, USA
Utpal B. Pajvani,
Columbia University Medical Center, USA
Inhibition of Notch Uncouples Akt Activation from Hepatic Lipid Accumulation by Decreasing mTorc1 Stability
Inhibition of Notch Uncouples Akt Activation from Hepatic Lipid Accumulation by Decreasing mTorc1 Stability
Rebecca A. Haeusler,
Columbia University, USA
FoxOs Regulate Liver Metabolic Fluxes
FoxOs Regulate Liver Metabolic Fluxes
Ana Paula Arruda,
Harvard School of Public Health, USA
Altered Mitochondria-Associated ER Membranes (MAMs) Links ER Stress to Mitochondrial Dysfunction in Obesity
Altered Mitochondria-Associated ER Membranes (MAMs) Links ER Stress to Mitochondrial Dysfunction in Obesity
Mads Fuglsang Kjolby,
Aarhus University, Denmark
The Ectodomain of SorCS1 Increases Peripheral Insulin Sensitivity and Lowers Plasma Glucose Levels in Mice
The Ectodomain of SorCS1 Increases Peripheral Insulin Sensitivity and Lowers Plasma Glucose Levels in Mice
Jeremie Boucher,
AstraZeneca, Sweden
A Novel Role for Insulin and IGF-1 Receptors in Control of Genomic Imprinting
A Novel Role for Insulin and IGF-1 Receptors in Control of Genomic Imprinting
Yingfeng Deng,
University of Texas Southwestern Medical Center, USA
Revisiting the Leloir Pathway: A Novel Connection between ER Stress and Insulin Sensitivity
Revisiting the Leloir Pathway: A Novel Connection between ER Stress and Insulin Sensitivity
Esther Phielix,
Maastricht UMC+, Netherlands
Reduction of Free Fatty Acids Lowers H2O2 Production But Does Not Restore Insulin-Stimulated Oxidative Capacity in Type 2 Diabetes
Reduction of Free Fatty Acids Lowers H2O2 Production But Does Not Restore Insulin-Stimulated Oxidative Capacity in Type 2 Diabetes
Darcy L. Johannsen,
Pennington Biomedical Research Center, USA
Insulin Resistance Driven by High-Fat Overfeeding Is Not Mediated by Muscular Lipid Accumulation
Insulin Resistance Driven by High-Fat Overfeeding Is Not Mediated by Muscular Lipid Accumulation
5:00—7:00 PM
Losing Fat: Dynamics of Adipocyte Lipid Turnover
*
Susan K. Fried,
Icahn School of Medicine at Mount Sinai, USA
Rudolf Zechner,
University of Graz, Austria
Lipolysis: A Drug Target for Metabolic Disease?
Lipolysis: A Drug Target for Metabolic Disease?
Paul F. Pilch,
Boston University School of Medicine, USA
Consequences of Cav(e)lin/Caveolae Deficiency on Lipid Metabolism
Consequences of Cav(e)lin/Caveolae Deficiency on Lipid Metabolism
Richard N. Bergman,
Cedars-Sinai Medical Center, USA
Role of Free Fatty Acids in the Insulin Resistance Syndrome
Role of Free Fatty Acids in the Insulin Resistance Syndrome
Irfan J. Lodhi,
Washington University School of Medicine, USA
Short Talk: Peroxisomal Lipid Synthesis Programs Adipose Tissue Development through PPAR Signaling
Short Talk: Peroxisomal Lipid Synthesis Programs Adipose Tissue Development through PPAR Signaling
5:00—7:00 PM
miRNAs and Metabolic Disease
*
Silvia Corvera,
University of Massachusetts Medical School, USA
Jens C. Brüning,
Max Planck Institute for Metabolism Research, Germany
miRNAs in Control of Liver Metabolism
miRNAs in Control of Liver Metabolism
Anna Krook,
Karolinska Institutet, Sweden
Role of miRNA Let7 in Diabetes-Related Inflammation
Role of miRNA Let7 in Diabetes-Related Inflammation
Thaís Amaral e Sousa,
University of São Paulo, Brazil
Short Talk: Deregulation of microRNAs Let-7b and miR-696 in Mice Insulin Resistant Skeletal Muscle
Short Talk: Deregulation of microRNAs Let-7b and miR-696 in Mice Insulin Resistant Skeletal Muscle
8:00—11:00 AM
Remodeling a Healthy Adipose Tissue
*
Stephen R. Farmer,
Boston University School of Medicine, USA
Silvia Corvera,
University of Massachusetts Medical School, USA
Metabolic Control of Adipose Tissue Angiogenesis
Metabolic Control of Adipose Tissue Angiogenesis
Chad A. Cowan,
Beth Israel Deaconess Medical Center, USA
Genome Editing to Generate Human Cellular Models of Metabolic Disease
Genome Editing to Generate Human Cellular Models of Metabolic Disease
Yun-Hee Lee,
Seoul National University, South Korea
Short Talk: Identification of an Adipogenic Niche for Adipose Tissue Remodeling and Restoration
Short Talk: Identification of an Adipogenic Niche for Adipose Tissue Remodeling and Restoration
Carolyn S. Hudak,
Harvard University, USA
Short Talk: Pref-1 Expressing Cells are the Adipose Precursors
Short Talk: Pref-1 Expressing Cells are the Adipose Precursors
Li Qiang,
Columbia University Medical Center, USA
Short Talk: Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of PPARgamma
Short Talk: Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of PPARgamma
8:00—11:00 AM
Aging, Mitochondria and Control of Metabolism
*
Gerald I. Shulman,
Yale University School of Medicine, USA
Andrew G. Dillin,
University of California, Berkeley, USA
Humoral Control of Mitochondrial Form and Function
Humoral Control of Mitochondrial Form and Function
Kitt F. Petersen,
Yale University School of Medicine, USA
Mitochondrial Function in Humans and its Relationship with Ectopic Lipid, Insulin Resistance and the Metabolic Syndrome
Mitochondrial Function in Humans and its Relationship with Ectopic Lipid, Insulin Resistance and the Metabolic Syndrome
Eric M. Verdin,
Buck Institute for Research on Aging, USA
Reversible Acetylation in Regulation of Mitochondrial Function and Aging
Reversible Acetylation in Regulation of Mitochondrial Function and Aging
Domenico Accili,
Columbia University, USA
Foxo2013: Can we Leverage some of its Properties to Treat Type 2 Diabetes
Foxo2013: Can we Leverage some of its Properties to Treat Type 2 Diabetes
Dudley W. Lamming,
Whitehead Institute for Biomedical Research, USA
Short Talk: Depletion of mTORC2 Impairs the Health and Longevity of Mice Independently of Effects on Hepatic Glucose Output
Short Talk: Depletion of mTORC2 Impairs the Health and Longevity of Mice Independently of Effects on Hepatic Glucose Output
5:00—7:00 PM
Epigenetics and Perinatal Imprinting in Diabetes and Obesity (Joint)
*
Philippe Froguel,
Imperial College of London, UK
C. Ronald Kahn,
Joslin Diabetes Center and Harvard Medical School, USA
Diabetes and Obesity - Nature or Nurture
Diabetes and Obesity - Nature or Nurture
Anne C. Ferguson-Smith,
University of Cambridge, UK
Intergenerational Epigenetic Programming of Metabolic Defects in a Mouse Model of Undernutrition
Intergenerational Epigenetic Programming of Metabolic Defects in a Mouse Model of Undernutrition
Paolo Sassone-Corsi,
University of California, Irvine, USA
Joining the Dots: Epigenetics, Metabolism and the Circadian Clock
Joining the Dots: Epigenetics, Metabolism and the Circadian Clock
8:00—11:00 AM
Signaling Defects and Inflammation in Insulin Resistance (Joint)
*
Gökhan S. Hotamisligil,
Harvard School of Public Health, USA
Diane Mathis,
Harvard Medical School, USA
Regulatory T Cells Residing in Adipose Tissue
Regulatory T Cells Residing in Adipose Tissue
Anthony W. Ferrante,
Columbia University, USA
Non-Inflammatory Functions of Adipose Tissue Macrophages
Non-Inflammatory Functions of Adipose Tissue Macrophages
Alan R. Saltiel,
University of California, San Diego, USA
Inflammatory Links between Obesity, Diabetes and Energy Expenditure
Inflammatory Links between Obesity, Diabetes and Energy Expenditure
Ajay Chawla,
Merck and University of California, San Francisco, USA
Innate Control of Metabolism
Innate Control of Metabolism
Jan Mauer,
Max Planck Institute for Neurological Research, Germany
Short Talk: IL-6 Signaling in Myeloid Cells Limits Obesity-Induced Insulin Resistance
Short Talk: IL-6 Signaling in Myeloid Cells Limits Obesity-Induced Insulin Resistance
2:30—3:30 PM
Workshop 2A: Islet Pathophysiology
*
Markus Stoffel,
ETH Zürich, Switzerland
Nicole Ehrhardt,
Cedars-Sinai Medical Center, USA
Lipase Maturation Factor 1 (LMF1): A New Player in ER-Stress and beta Cell Function
Lipase Maturation Factor 1 (LMF1): A New Player in ER-Stress and beta Cell Function
Yun Sok Lee,
University of California, San Diego, USA
A Novel Pathway for Regulation of Insulin Secretion by Fractalkine and CX3CR1 System
A Novel Pathway for Regulation of Insulin Secretion by Fractalkine and CX3CR1 System
Jean-Sébastien Annicotte,
EGID CNRS UMR 8199, France
The P300/CBP-Associated Factor (PCAF) Is a Histone Acetyl Transferase that Controls beta-Cell Function
The P300/CBP-Associated Factor (PCAF) Is a Histone Acetyl Transferase that Controls beta-Cell Function
Veronika Leiss,
University Tübingen, Germany
Role of Islet Galphai2 in the Regulation of Glucose Homeostasis
Role of Islet Galphai2 in the Regulation of Glucose Homeostasis
3:30—4:30 PM
Workshop 2B: New Drugs for Diabetes
*
Hans Ulrich Stilz,
Novo Nordisk A/S, Denmark
Annelie Falkevall,
Karolinska Institutet, Sweden
Targeting VEGF-B as a Novel Treatment for Insulin Resistance and Type 2 Diabetes
Targeting VEGF-B as a Novel Treatment for Insulin Resistance and Type 2 Diabetes
James D. Dunbar,
Eli Lilly & Company, USA
Comparison of the in vitro and in vivo Actions of FGF19 and FGF21
Comparison of the in vitro and in vivo Actions of FGF19 and FGF21
Derek M. Erion,
Takeda, USA
Hepato-Selective Glucokinase Activators Reduce Fasting and Postprandial Hyperglycemia in Rats without Inducing Hypoglycemia or Increasing Hepatic Lipids
Hepato-Selective Glucokinase Activators Reduce Fasting and Postprandial Hyperglycemia in Rats without Inducing Hypoglycemia or Increasing Hepatic Lipids
Safina Ali,
Samuel Lunenfeld Research Institute, Canada
Disruption of Cardiomyocyte Glucagon Receptor Signaling Decreases Flux through Fatty Acid Oxidation and Enhances Survival Following Ischemic Injury
Disruption of Cardiomyocyte Glucagon Receptor Signaling Decreases Flux through Fatty Acid Oxidation and Enhances Survival Following Ischemic Injury
5:00—7:00 PM
Variation in the Biology of Adipose Depots
*
Jacqueline M. Stephens,
Louisiana State University, USA
Susan K. Fried,
Icahn School of Medicine at Mount Sinai, USA
Fat Distribution in Men and Women: The Biology of Pear Shape
Fat Distribution in Men and Women: The Biology of Pear Shape
James L. Kirkland,
Mayo Clinic, USA
Cellular Senescence and Adipose Tissue
Cellular Senescence and Adipose Tissue
Elise C. Jeffery,
Yale University, USA
Short Talk: Regulation of Adipocyte Precursor Cells in Obesity
Short Talk: Regulation of Adipocyte Precursor Cells in Obesity
Sagar P. Bapat,
University of California, San Francisco, USA
Short Talk: Sexually Dimorphic Properties of Fat Resident Regulatory T Cells
Short Talk: Sexually Dimorphic Properties of Fat Resident Regulatory T Cells
5:00—7:00 PM
Gastric Bypass Surgery and the Gut in Control of Metabolism
*
Mary-Elizabeth Patti,
Joslin Diabetes Center, USA
David E. Cummings,
University of Washington, USA
Metabolic Surgery: Endocrine Mechanisms of Diabetes Remission after "Bariatric" Operations
Metabolic Surgery: Endocrine Mechanisms of Diabetes Remission after "Bariatric" Operations
Lee M. Kaplan,
Massachusetts General Hospital, USA
Contributions of the Gut Microbiota to the Physiological Response to Geriatric Bypass
Contributions of the Gut Microbiota to the Physiological Response to Geriatric Bypass
Line V. Kristensen,
University of Copenhagen, Denmark
Short Talk: GPR40, GPR120 and GPR119 Act in Concert as Enteroendocrine Sensors for Dietary Fat
Short Talk: GPR40, GPR120 and GPR119 Act in Concert as Enteroendocrine Sensors for Dietary Fat
8:00—11:00 AM
Brown Adipose Tissue: Where There Is Smoke...
*
Eleftheria Maratos-Flier,
Beth Israel Deaconess Medical Center, USA
Stephen R. Farmer,
Boston University School of Medicine, USA
Progenitor Morphology and Development of Beige Adipocytes
Progenitor Morphology and Development of Beige Adipocytes
Sheila Collins,
Vanderbilt University Medical Center, USA
Converging Hormonal Signals that 'Spark' the Brown-in-White Adipocyte Expansion
Converging Hormonal Signals that 'Spark' the Brown-in-White Adipocyte Expansion
Yu-Hua Tseng,
Joslin Diabetes Center/Harvard Medical School, USA
Cross Talk between Constitutive and Recruitable Brown Adipose Tissues for Thermoregulation and Energy Homeostasis
Cross Talk between Constitutive and Recruitable Brown Adipose Tissues for Thermoregulation and Energy Homeostasis
Sona Rajakumari,
University of Pennsylvania, USA
Short Talk: EBF2 Determines and Maintains Brown Adipocyte Identity
Short Talk: EBF2 Determines and Maintains Brown Adipocyte Identity
Xingxing Kong,
Beth Israel Deaconess Medical Center, Harvard Medical School, USA
Short Talk: Thermogenic Actions of Interferon Regulatory Factor 4 (IRF4)
Short Talk: Thermogenic Actions of Interferon Regulatory Factor 4 (IRF4)
8:00—11:00 AM
Metabolic Mediators of Insulin Resistance
*
Jeffrey Flier,
Harvard University, USA
*
Barbara C. Hansen,
University of South Florida, Tampa, USA
Philipp E. Scherer,
University of Texas Southwestern Medical Center, USA
Inflammation, UPR and Lipids: All about Stress and Toxicity?
Inflammation, UPR and Lipids: All about Stress and Toxicity?
Gerald I. Shulman,
Yale University School of Medicine, USA
Novel PKCs as Mediators of Liver and Muscle Insulin Resistance in Humans
Novel PKCs as Mediators of Liver and Muscle Insulin Resistance in Humans
Gökhan S. Hotamisligil,
Harvard School of Public Health, USA
Endoplasmic Reticulum Stress as a Mediator of Insulin Resistance
Endoplasmic Reticulum Stress as a Mediator of Insulin Resistance
Greg Steinberg,
McMaster University, Canada
AMP-Activated Protein Kinase (AMPK) Regulation of Lipid Metabolism and Insulin Sensitivity
AMP-Activated Protein Kinase (AMPK) Regulation of Lipid Metabolism and Insulin Sensitivity
Alexei Kharitonenkov,
Novo Nordisk, USA
Short Talk: Rational Design and Efficacy of LY2405319, an FGF21-Based Clinical Candidate
Short Talk: Rational Design and Efficacy of LY2405319, an FGF21-Based Clinical Candidate
2:30—4:30 PM
Workshop 2: Assessing Immune Cell Populations in Adipose Tissue: What Are the FACS?
*
Anthony W. Ferrante,
Columbia University, USA
Yoshihiro Ogawa,
Kyushu University, Japan
Role of Macrophage-Inducible C-Type Lectin in Obesity-Induced Adipose Tissue Inflammation
Role of Macrophage-Inducible C-Type Lectin in Obesity-Induced Adipose Tissue Inflammation
Dwight J. Klemm,
University of Colorado Denver Anschutz Medical Center, USA
Soluble Adipose Tissue Factors Stimulate de Novo Differentiation of Bona Fide Adipocytes from Bone Marrow Myeloid Cells
Soluble Adipose Tissue Factors Stimulate de Novo Differentiation of Bona Fide Adipocytes from Bone Marrow Myeloid Cells
John S. Parks,
Wake Forest School of Medicine, USA
Dietary Cholesterol Promotes Adipocyte Hypertrophy and Inflammation in Visceral, But Not Subcutaneous, Fat in Non-Human Primates
Dietary Cholesterol Promotes Adipocyte Hypertrophy and Inflammation in Visceral, But Not Subcutaneous, Fat in Non-Human Primates
Tal Pecht,
Ben-Gurion University of the Negev, Israel
Adipose Tissue Foam Cells in Human Obesity
Adipose Tissue Foam Cells in Human Obesity
Marek Wagner,
University of Bergen, Norway
Adipose Tissue-Derived Macrophages, Endothelial Cells and Cancer
Adipose Tissue-Derived Macrophages, Endothelial Cells and Cancer
Nicolas Venteclef,
Institute of Cardiometabolism and Nutrition, France
Dysregulation of a GPS2/SMRT Corepressor Pathway in Adipocytes Coincides with Adipose Tissue Inflammation in Human Obesity
Dysregulation of a GPS2/SMRT Corepressor Pathway in Adipocytes Coincides with Adipose Tissue Inflammation in Human Obesity
Maryam Rakhshandehroo,
Utrecht Medical Center, Netherlands
iNKTs in Adipose Tissue Prevent Insulin Resistance
iNKTs in Adipose Tissue Prevent Insulin Resistance
5:00—7:00 PM
Beyond Diabetes - Complications of Obesity
*
Ira J. Goldberg,
New York University, USA
Kathryn J. Moore,
New York University Medical Center, USA
Mechanisms of Macrophage Retention in Metabolic Diseases
Mechanisms of Macrophage Retention in Metabolic Diseases
Mikhail G. Kolonin,
University of Texas Health Sciences Center, USA
Regulation of Tumor Progression by Adipose Tissue
Regulation of Tumor Progression by Adipose Tissue
Scott A. Small,
Columbia University, USA
Branch-Chained Amino Acids Link Obesity/T2DM and Alzheimer’s Disease through Retromer Deficiency
Branch-Chained Amino Acids Link Obesity/T2DM and Alzheimer’s Disease through Retromer Deficiency
Roberta Goncalves Marangoni,
Northwestern University, USA
Short Talk: Aberrant Adipogenesis in the Pathogenesis of Scleroderma
Short Talk: Aberrant Adipogenesis in the Pathogenesis of Scleroderma
5:00—7:00 PM
CNS Control of Metabolism
*
Jens C. Brüning,
Max Planck Institute for Metabolism Research, Germany
Joel K. Elmquist,
University of Texas Southwestern Medical Center, USA
Investigating Autonomic Regulatory Networks Controlling Energy Balance and Glucose Homeostasis
Investigating Autonomic Regulatory Networks Controlling Energy Balance and Glucose Homeostasis
Christoph Buettner,
Mount Sinai School of Medicine, USA
CNS Control of Adipose Tissue Functionality
CNS Control of Adipose Tissue Functionality
Richard M. Caprioli,
Vanderbilt University Medical Center, USA
Imaging Mass Spectrometry: A New Technology for the Direct Mapping of Endogenous Compounds in Tissue
Imaging Mass Spectrometry: A New Technology for the Direct Mapping of Endogenous Compounds in Tissue
Celine E. Riera,
Cedars-Sinai Medical Center, USA
Short Talk: Neuroendocrine Regulation of the Calcineurin/CRTC1 Longevity Circuit in C. elegans and Mice
Short Talk: Neuroendocrine Regulation of the Calcineurin/CRTC1 Longevity Circuit in C. elegans and Mice
*Session Chair †Invited, not yet responded.
We gratefully acknowledge support for this conference from:
We gratefully acknowledge the generous grant for this conference provided by:
We gratefully acknowledge additional support for this conference from:
|
|
|
|
|
Journal of Lipid Research |
|
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Corporate Relations, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org, Phone:+1 970-262-1179 |
